ARCHIVES

NCI Advisory Group, Other Cancer Meetings

This article is from The Cancer Letter archive.

Vol. 12 No. 09 | February 28, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Sandra Swain Elected ASCO President for 2012

December 10, 2010

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

NCI To Stop All Support For WHT After March 31

February 5, 1988